Tweet, Tweet, Tweet: Pharma Finding Its Niche?
Executive Summary
The industry has been slow to adopt new technologies in the highly regulated pharma world, but both big and small biopharmas alike are beginning to find their comfort zone with limited-character media like Twitter.
You may also be interested in...
Hemophilia Market Snapshot: Is There Enough Innovation For Patients To Switch?
A cautious patient population with long memories could thwart the potential of new hemophilia A treatments, even as the market leaders promise Wall Street that switching patients will be no problem.
Social Media Marketing: FDA’s Old-Time Approach May Turn Industry Away
Draft guidances say tweets about a product must balance benefit and risk information, and firms cannot be selective in correcting information on third-party sites.
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
FDA’s draft guidance on presenting product information on social media platforms with character space limitations includes an equation for sending a tweet.